How botulinum toxin reduces sweating

Every eccrine sweat gland has a nerve ending sitting against it. When the nervous system decides you need to cool down, that nerve ending releases a chemical messenger called acetylcholine into the tiny gap between nerve and gland. The gland detects it and produces sweat. No messenger, no sweat.

There is a quirk here that surprises people who know some physiology. Sweat glands are controlled by the sympathetic nervous system, the fight-or-flight branch, which almost everywhere else in the body uses adrenaline as its messenger. The sweat glands are the notable exception: sympathetic wiring, but a cholinergic messenger. That exception is precisely what makes this treatment possible.

Botulinum toxin does not destroy the sweat gland, shrink it, or block the duct. It acts on the nerve ending, preventing it from releasing acetylcholine. The instruction is never sent, and the gland, which remains entirely intact, sits idle.

This is the same molecular action used when treating facial lines. There the target is the messenger travelling from nerve to muscle; here it is the messenger travelling from nerve to gland. One mechanism, two destinations.

Because the injections are placed very superficially into the skin of the treated area, and because the molecule does not travel meaningfully beyond where it is placed, the effect stays where it is put. This is why underarm treatment does not affect your ability to sweat elsewhere, and why it does not reduce sweating as a whole-body function.

The blockade is not permanent. Over time the treated nerve endings form new terminals and resume releasing their messenger, and sweating returns gradually to its previous level. How long that takes varies considerably between individuals, which is why any specific figure is misleading.

Reversibility is a feature rather than a limitation. It means a treatment that does not suit you does not have to be lived with, and it means nothing has been permanently removed from a system you may need later.

The effect also does not appear immediately. Nerve terminals take a few days to be affected, and the full result develops over a couple of weeks. Anyone planning treatment around a specific event or season should allow for that gap rather than book at the last moment.

It does not cure hyperhidrosis. The underlying over-active signalling is unchanged; the treatment interrupts its final step for a period.

It does not stop sweating completely in the treated area, and aiming for zero is neither the goal nor a realistic expectation. The objective is to bring sweating down to a level that no longer dictates daily decisions. How much reduction any individual gets varies.

It does not directly target body odour, which comes from a different set of glands and from skin bacteria. Many people notice odour improves anyway, because a drier underarm is a less hospitable environment, but that is a side effect rather than the mechanism.

And it does not replace assessment. If the sweating pattern suggests a secondary cause, treating the skin does not address what is producing the signal.

Assessment comes first, covering the history that separates primary from secondary sweating, your medical background and your medications. Where injectable treatment is agreed, the active area may be mapped beforehand with a simple starch-iodine test, which turns the most active skin a dark colour and shows where treatment should be concentrated.

The injections themselves are numerous but very shallow and the appointment is short. Most people return to their day directly. Small marks or mild redness at the injection points are common and settle quickly.

The underarms are the most straightforward area to treat. Palms and soles are also treated but are considerably more sensitive, and hand treatment carries a recognised possibility of temporary weakness in the small muscles of the hand, which needs to be weighed against the benefit if your work depends on fine grip. Facial and scalp sweating requires particular care because of the muscles nearby.

This is a prescription medical treatment and it has clear exclusions. It is not given during pregnancy or breastfeeding. It is avoided in people with certain neuromuscular disorders, and in anyone who has previously reacted to it. Active infection or inflamed skin at the treatment site means postponing. Some medications interact with it, which is another reason the full list matters at the consultation.

It should be administered by a licensed doctor in a licensed facility, and this is worth being firm about. The treatment is safe in appropriate hands and the questions asked beforehand are as much a part of that safety as the technique itself.